Cargando…

Corrigendum: Co-stimulation with TLR7 agonist imiquimod and inactivated Influenza virus particles promotes mouse B cell activation, differentiation, and accelerated antigen specific antibody production

Detalles Bibliográficos
Autores principales:	Li, Can, To, Kelvin K.W., Zhang, Anna J. X., Lee, Andrew C.Y., Zhu, Houshun, Mak, Winger W.N., Hung, Ivan F. N., Yuen, Kwok-Yung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634755/ https://www.ncbi.nlm.nih.gov/pubmed/36341429 http://dx.doi.org/10.3389/fimmu.2022.1053779

Ejemplares similares

Co-stimulation With TLR7 Agonist Imiquimod and Inactivated Influenza Virus Particles Promotes Mouse B Cell Activation, Differentiation, and Accelerated Antigen Specific Antibody Production
por: Li, Can, et al.
Publicado: (2018)

H7N9 influenza A virus activation of necroptosis in human monocytes links innate and adaptive immune responses
por: Lee, Andrew C. Y., et al.
Publicado: (2019)

The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
por: Zhang, Li, et al.
Publicado: (2015)

The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer
por: Demaria, Sandra, et al.
Publicado: (2013)

Could imiquimod (Aldara 5% cream) or other TLR7 agonists be used in the treatment of COVID-19?
por: Avcilar, Huseyin, et al.
Publicado: (2020)

First-Line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony
por: Miranda-Verastegui, Cesar, et al.
Publicado: (2009)

In memory of Patrick Manson, founding father of tropical medicine and the discovery of vector-borne infections
por: To, Kelvin KW, et al.
Publicado: (2012)

Low population serum microneutralization antibody titer against the predominating influenza A(H3N2) N121K virus during the severe influenza summer peak of Hong Kong in 2017
por: Zhu, Houshun, et al.
Publicado: (2018)

A Systematic Approach to Novel Virus Discovery in Emerging Infectious Disease Outbreaks
por: Sridhar, Siddharth, et al.
Publicado: (2015)

The Toll-Like Receptor Agonist Imiquimod Is Active against Prions
por: Oumata, Nassima, et al.
Publicado: (2013)

Tumor eradicated by combination of imiquimod and OX40 agonist for in situ vaccination
por: Chu, Yanhong, et al.
Publicado: (2021)

Roles of TLR7 in Activation of NF-κB Signaling of Keratinocytes by Imiquimod
por: Li, Zheng Jun, et al.
Publicado: (2013)

Toll-like Receptor 7 (TLR7) Is Expressed in Adipocytes and the Pharmacological TLR7 Agonist Imiquimod and Adipocyte-Derived Cell-Free Nucleic Acids (cfDNA) Regulate Adipocyte Function
por: Thomalla, Miriam, et al.
Publicado: (2022)

Imiquimod (Aldara cream).
por: Buck, H W
Publicado: (1998)

Donor-Derived Genotype 4 Hepatitis E Virus Infection, Hong Kong, China, 2018
por: Sridhar, Siddharth, et al.
Publicado: (2019)

The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma
por: Cho, Jeong Hyun, et al.
Publicado: (2017)

Avian Influenza A H7N9 Virus Induces Severe Pneumonia in Mice without Prior Adaptation and Responds to a Combination of Zanamivir and COX-2 Inhibitor
por: Li, Can, et al.
Publicado: (2014)

The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities
por: To, Kelvin KW, et al.
Publicado: (2013)

Dermatomyositis flare on imiquimod therapy highlights a crucial role of aberrant TLR7 signalling
por: Meyer, Alain, et al.
Publicado: (2016)

Ebola virus disease: a highly fatal infectious disease reemerging in West Africa
por: To, Kelvin K.W., et al.
Publicado: (2015)

Coronavirus HKU15 in respiratory tract of pigs and first discovery of coronavirus quasispecies in 5′-untranslated region
por: Woo, Patrick CY, et al.
Publicado: (2017)

Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists
por: Cheng, Kui, et al.
Publicado: (2015)

Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19
por: Angelopoulou, Athina, et al.
Publicado: (2020)

TLR7 Stimulation With Imiquimod Induces Selective Autophagy and Controls Mycobacterium tuberculosis Growth in Mouse Macrophages
por: Lee, Hyo-Ji, et al.
Publicado: (2020)

Human metapneumovirus infection in an immunocompetent adult presenting as mononucleosis-like illness
por: Li, Iris W.S., et al.
Publicado: (2008)

Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?
por: Chan, Jasper F.W., et al.
Publicado: (2012)

The Systemic Response to Topical Aldara Treatment is Mediated Through Direct TLR7 Stimulation as Imiquimod Enters the Circulation
por: Nerurkar, Louis, et al.
Publicado: (2017)

TLR7 Activation of Macrophages by Imiquimod Inhibits HIV Infection through Modulation of Viral Entry Cellular Factors
por: Meng, Feng-Zhen, et al.
Publicado: (2021)

Additional molecular testing of saliva specimens improves the detection of respiratory viruses
por: To, Kelvin KW, et al.
Publicado: (2017)

Deoxyguanosine is a TLR7 agonist
por: Davenne, Tamara, et al.
Publicado: (2019)

NOD2 Agonist Promotes the Production of Inflammatory Cytokines in VSMC in Synergy with TLR2 and TLR4 Agonists
por: Sun, Jinghua, et al.
Publicado: (2012)

TLR4 Inactivation in Myeloid Cells Accelerates Bone Healing of a Calvarial Defect Model in Mice
por: Wang, Dan, et al.
Publicado: (2017)

Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy
por: Poulas, Konstantinos, et al.
Publicado: (2020)

Comparison of human B cell activation by TLR7 and TLR9 agonists
por: Hanten, John A, et al.
Publicado: (2008)

Trial Watch: experimental TLR7/TLR8 agonists for oncological indications
por: Frega, Giorgio, et al.
Publicado: (2020)

The role of TLR7 agonists in modulating COVID-19 severity in subjects with loss-of-function TLR7 variants
por: Naushad, Shaik Mohammad, et al.
Publicado: (2023)

Corrigendum: NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells
por: Alrefai, Hani, et al.
Publicado: (2016)

Seroprevalence of SARS-CoV-2 in Hong Kong returnees – Authors' reply
por: To, Kelvin Kai-Wang, et al.
Publicado: (2020)

Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells
por: Chuang, Jiin-Haur, et al.
Publicado: (2011)

Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells
por: Shen, Kuan-Yin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g0t5rdm5svihnli22n75gm93u3